Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

OXY-NASE NASAL DROPS 0.025%

Approval Number

SIN09618P

Drug Name

OXY-NASE NASAL DROPS 0.025%

Product Name

OXY-NASE NASAL DROPS 0.025%

Approval Date

February 4, 1998

Registrant

ZUELLIG PHARMA PTE. LTD.

Licence Holder

ZUELLIG PHARMA PTE. LTD.

Regulatory Information

Registrant

ZUELLIG PHARMA PTE. LTD.

Licence Holder

ZUELLIG PHARMA PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

General Sale List

Formulation Information

Dosage Form

SOLUTION

Route of Administration

NASAL

Medical Information

ATC Code

R01AA05

ATC Item Name

oxymetazoline

Manufacturer Information

Pharmaceutical Manufacturer

ZUELLIG PHARMA PTE. LTD.

Manufacturers

HOE PHARMACEUTICALS SDN BHD

Active Ingredients

Ingredient Name

OXYMETAZOLINE HCl

Strength

0.025% w/v

Drug MonographOxymetazoline

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy